Pure Global AI
NCT06361368Recruiting

Efficacy Assessment of Probiotics in Improving Sleep Indices

National Yang Ming UniversityClinicalTrials.govdietary supplement
Verified
Study focus
Disease/Condition
Insomnia
Drug/Device/Intervention
PS150
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
National Yang Ming University
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Apr 11, 2024
End date
Mar 01, 2026
Enrollment
140 participants
Primary outcome

Polysomnography (PSG)

Summary

To determine whether PS150 (1) reduces insomnia symptoms, (2) improves sleep quality, (3)
 adjusts autonomic nervous system functioning, (4) reduces the severity of anxiety and
 depressive symptoms, and (5) adjusts microbiome and endocrine functions.

ICD-10 classifications
Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]Sleep disordersSleep disorder, unspecifiedOther sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06361368
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06361368 through Pure Global AI's free database. This phase not specified trial is sponsored by National Yang Ming University and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.